Conatus Pharmaceuticals Inc. 4
4 · Conatus Pharmaceuticals Inc. · Filed Apr 4, 2016
Insider Transaction Report
Form 4
Smith Edward F III
SVP, Reg Affairs and QA
Transactions
- Award
Stock Option (Right to Buy)
2016-04-01+100,000→ 100,000 totalExercise: $2.53Exp: 2026-03-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 1, 2016. Twenty-five percent (25%) of the total number of shares of common stock subject to the option will vest on April 1, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.